Lab Automation: Everyone Re-invents the Wheel

March 2010. The molecular diagnostics industry is aiming at automation of the screening process spanning over three core steps: sample preparation, analysis, and detection. The Achilles’ heel of laboratory instrument development is a persisting lack of interconnectivity or cross-company standards which demanding customers require.

Big pharma customers are not anymore happy with suppliers’ marketing strategies of divide et impera – divide customers, fragment markets they are in, and conquer these. Michael Collasius, Vice President Automated Systems Qiagen NV, discussed with B2Bioworld the issues. With an addendum by Peer Michael Schatz.Reading time: 5 min

Read Now:
1,00 EUR (incl. 7% VAT)

Back to section